Page last updated: 2024-10-18

dalteparin and Sclerosis, Systemic

dalteparin has been researched along with Sclerosis, Systemic in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"Authors describe a case of systemic sclerosis with deep venous thrombosis."1.34[Hereditary thrombophilia and systemic sclerosis. An unusual case report]. ( Albanese, L; D'Amore, M; D'Amore, S; Minenna, G; Scagliusi, P, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Minenna, G1
Albanese, L1
D'Amore, S1
Scagliusi, P1
D'Amore, M1

Other Studies

1 other study available for dalteparin and Sclerosis, Systemic

ArticleYear
[Hereditary thrombophilia and systemic sclerosis. An unusual case report].
    Recenti progressi in medicina, 2007, Volume: 98, Issue:3

    Topics: Adult; Anticoagulants; Blood Coagulation Disorders, Inherited; Drug Therapy, Combination; Enoxaparin

2007